Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
14
×
national blog main
biotech
life sciences
boston top stories
national top stories
clinical trials
boston
startups
deals
fda
san francisco blog main
new york blog main
san diego blog main
national
raleigh-durham blog main
san diego top stories
san francisco top stories
texas blog main
texas top stories
venture capital
boulder/denver blog main
cancer diagnostics
detroit blog main
indiana blog main
innovation
ipo
medical device
medical devices
new york top stories
novartis
raleigh-durham top stories
seattle blog main
software
vc
wisconsin blog main
abbvie
amgen
arvinas
bayer
What
company
14
×
ipo
developing
million
drug
medicines
close
new
public
raised
raises
tests
advance
announced
bio
biology
biotech
blood
brings
cancer
device
digital
files
firms
genetic
investors
life
plans
science
synthetic
therapeutics
treatment
way
week
acquire
acquisitions
agreed
aiming
albert
analysis
Language
unset
unknown
Current search:
company
×
" boston blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com
5 years ago
DermaClip Ramps Up for U.S. Sales Push of Wound-Healing Device
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com
5 years ago
Iora Health Goes Big With $100M to Advance Collaborative Care Model